DK0691342T3 - Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem - Google Patents

Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem

Info

Publication number
DK0691342T3
DK0691342T3 DK95401607T DK95401607T DK0691342T3 DK 0691342 T3 DK0691342 T3 DK 0691342T3 DK 95401607 T DK95401607 T DK 95401607T DK 95401607 T DK95401607 T DK 95401607T DK 0691342 T3 DK0691342 T3 DK 0691342T3
Authority
DK
Denmark
Prior art keywords
alkyl
halo
alkoxy
hydroxy
processes
Prior art date
Application number
DK95401607T
Other languages
English (en)
Inventor
Gilbert Lavielle
Thierry Dubuffet
Mark Millan
Adrian Newman-Tancredi
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0691342T3 publication Critical patent/DK0691342T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK95401607T 1994-07-06 1995-07-05 Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem DK0691342T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408328A FR2722194B1 (fr) 1994-07-06 1994-07-06 Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0691342T3 true DK0691342T3 (da) 1999-11-08

Family

ID=9465049

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95401607T DK0691342T3 (da) 1994-07-06 1995-07-05 Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem

Country Status (16)

Country Link
US (2) US5663191A (da)
EP (1) EP0691342B1 (da)
JP (1) JP2999139B2 (da)
CN (1) CN1049660C (da)
AT (1) ATE179421T1 (da)
AU (1) AU684165B2 (da)
CA (1) CA2153195C (da)
DE (1) DE69509308T2 (da)
DK (1) DK0691342T3 (da)
ES (1) ES2133686T3 (da)
FI (1) FI111945B (da)
FR (1) FR2722194B1 (da)
GR (1) GR3030168T3 (da)
NO (1) NO311085B1 (da)
NZ (1) NZ272501A (da)
ZA (1) ZA955631B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891882A (en) * 1996-12-06 1999-04-06 Abbott Laboratories Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5919802A (en) * 1997-12-05 1999-07-06 Princeton University Methods of preventing and/or treating temporal lobe epilepsy
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
FR2823752B1 (fr) * 2001-04-18 2004-10-22 Servier Lab Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0118892D0 (en) * 2001-08-02 2001-09-26 Vernalis Res Ltd Method of treatment
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
AU2006214233A1 (en) * 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
ES2335710T3 (es) * 2006-04-03 2010-03-31 F. Hoffmann-La Roche Ag Proceso para preparar acidos beta-aril o heteroaril carboxi-licos ciclicos enantiomericamente enriquecidos.
TW200924752A (en) 2007-09-17 2009-06-16 Organon Nv Tricyclic heterocyclic derivatives
WO2010069793A1 (en) * 2008-12-16 2010-06-24 F. Hoffmann-La Roche Ag Process for the preparation of pyrollidine-3-carboxylic acids
FR2948372B1 (fr) * 2009-07-21 2011-07-22 Servier Lab Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN105111220A (zh) * 2015-09-12 2015-12-02 浙江大学 取代1,4-二氢苯并吡喃[2,3-b]吡咯化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518272A (en) * 1968-02-05 1970-06-30 Warner Lambert Pharmaceutical Tetrahydro benzopyranoquinolines and process for their production
US3888946A (en) * 1971-03-17 1975-06-10 Little Inc A Pyrano benzopyrans
AU560459B2 (en) * 1982-06-01 1987-04-09 Abbott Laboratories Tetrahydro-benzo(e) isoindolines
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents
JPH03502701A (ja) * 1988-12-15 1991-06-20 アボツト・ラボラトリーズ ５‐ｈｔ選択性物質
GB8917333D0 (en) * 1989-07-28 1989-09-13 Merck Sharp & Dohme Therapeutic agents
FR2687146B1 (fr) * 1992-02-12 1994-04-01 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
CN1119189A (zh) 1996-03-27
ES2133686T3 (es) 1999-09-16
AU684165B2 (en) 1997-12-04
JPH0841066A (ja) 1996-02-13
DE69509308T2 (de) 1999-11-25
US5663191A (en) 1997-09-02
NO952660D0 (no) 1995-07-05
ATE179421T1 (de) 1999-05-15
EP0691342A1 (fr) 1996-01-10
EP0691342B1 (fr) 1999-04-28
FI953308A (fi) 1996-01-07
CN1049660C (zh) 2000-02-23
FI953308A0 (fi) 1995-07-05
CA2153195C (fr) 2004-06-15
US5723484A (en) 1998-03-03
FI111945B (fi) 2003-10-15
GR3030168T3 (en) 1999-08-31
ZA955631B (en) 1996-02-16
NO952660L (no) 1996-01-08
FR2722194B1 (fr) 1996-08-23
NZ272501A (en) 1996-03-26
FR2722194A1 (fr) 1996-01-12
NO311085B1 (no) 2001-10-08
DE69509308D1 (de) 1999-06-02
CA2153195A1 (fr) 1996-01-07
AU2482695A (en) 1996-01-18
JP2999139B2 (ja) 2000-01-17

Similar Documents

Publication Publication Date Title
DK0691342T3 (da) Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
HN1998000074A (es) Derivados de macrolidos c-4 sustituidos
TR199902995T2 (xx) 9-Oksim eritromisin t�revleri
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
EA199901015A1 (ru) 4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а
DK537289D0 (da) 4h-1-benzopyran-4-on-derivater, deres fremstilling og anvendelse
DK91692A (da) Halogenerede nucleosidderivater, saadanne forbindelser til anvendelse mod en adenovirusinfektion, anvendelse af forbindelserne til fremstilling af et laegemiddel mod en adenovirusinfektion, farmaceutiske praeparater indeholdende forbindelserne samt fremgangsmaade til fremstilling af forbindelserne
NO930768D0 (no) Substituerte aminofosfonatderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
DK0486386T3 (da) Hidtil ukendte N-benzoylprolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES8308567A1 (es) Procedimiento para la preparacion de derivados de penem.
IL112102A0 (en) Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
NO972943L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse
FR2596760B1 (fr) Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique
IL61911A0 (en) 2,3-dihydro-imidazo(1,2-b)pyridazine derivatives,their preparation and pharmaceutical compositions containing them
TNSN98061A1 (fr) Derives d'erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
NO911508L (no) Nytt s-timololderivat og fremgangsmaate for dets fremstilling.
NO306300B1 (no) 3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler
DK0574312T3 (da) Diacylglycerolnicotinater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
IL81258A (en) Dihydropyridinelactols,their preparation and pharmaceutical compositions containing them
DK48489A (da) Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
FI890173A0 (fi) Isoxazoler med nootropisk verkan.